A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
Abstract Background This study aims to evaluate the effect of subcutaneous (SC) elamipretide dosing on exercise performance using the 6 min walk test (6MWT), patient‐reported outcomes measuring fatigue, functional assessments, and safety to guide the development of the Phase 3 trial. Methods MMPOWER...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2020-08-01
|
| Reeks: | Journal of Cachexia, Sarcopenia and Muscle |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/jcsm.12559 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|